$BDSX stock has now risen 14% today, according to our price data from Polygon. There has been approximately $4,448,577 of trading volume.
Here is what we see in our data on $BDSX (you can track the company live on Quiver's $BDSX stock page):
$BDSX Insider Trading Activity
$BDSX insiders have traded $BDSX stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BDSX stock by insiders over the last 6 months:
- JACK W SCHULER has made 3 purchases buying 42,600 shares for an estimated $1,032,931 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BDSX Hedge Fund Activity
We have seen 21 institutional investors add shares of $BDSX stock to their portfolio, and 26 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 169,359 shares (+40.7%) to their portfolio in Q2 2026, for an estimated $3,819,045
- MONASHEE INVESTMENT MANAGEMENT LLC removed 112,344 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,628,988
- ESSEX INVESTMENT MANAGEMENT CO LLC added 109,829 shares (+83.1%) to their portfolio in Q2 2026, for an estimated $2,476,643
- PERCEPTIVE ADVISORS LLC added 108,694 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,451,049
- AIGH CAPITAL MANAGEMENT LLC removed 80,000 shares (-10.5%) from their portfolio in Q2 2026, for an estimated $1,804,000
- ABERDEEN GROUP PLC removed 69,799 shares (-15.2%) from their portfolio in Q2 2026, for an estimated $1,573,967
- JANE STREET GROUP, LLC added 64,475 shares (+238.5%) to their portfolio in Q2 2026, for an estimated $1,453,911
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$BDSX Revenue
$BDSX had revenues of $26.9M in Q2 2026. This is an increase of 34.18% from the same period in the prior year.
You can track BDSX financials on Quiver Quantitative's BDSX stock page.
You can access data on BDSX stock through the Quiver Quantitative API.
$BDSX Government Contracts
We have seen $441,974 of award payments to $BDSX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STX NODIFY LUNG CANCER SCREENING SERVICES: $390,678
- SINGLE AWARD IDIQ FOR NODIFY LUNG BLOOD TESTING - VISN23: $10,600
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$BDSX Analyst Ratings
Wall Street analysts have issued reports on $BDSX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 02/27/2026
To track analyst ratings and price targets for $BDSX, check out Quiver Quantitative's $BDSX forecast page.
$BDSX Price Targets
Multiple analysts have issued price targets for $BDSX recently. We have seen 3 analysts offer price targets for $BDSX in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Max Masucci from Roth Capital set a target price of $32.0 on 06/25/2026
- Kyle Mikson from Canaccord Genuity set a target price of $27.0 on 06/18/2026
- Yi Chen from HC Wainwright & Co. set a target price of $26.0 on 06/15/2026
You can track data on $BDSX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
